SCHEMBL9607437

SCHEMBL9607437

O=Cc1cncc(-c2ccc(OC(F)(F)F)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIP4K2A P48426 1/20 0.57
SCN10A Q9Y5Y9 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
ABL1 P00519 5/20 0.45
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
OPRM1 P35372 1/20 0.43
KCNH2 Q12809 1/20 0.43
AURKA O14965 1/20 0.40
TPX2 Q9ULW0 1/20 0.40
SCN5A Q14524 4/20 0.40
KIF11 P52732 1/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
NPY5R Q15761 1/20 0.39
SCN9A Q15858 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1230329 0.91 PIP4K2A (0.51) PIP4K2ASCN10APRMT6ABL1CA12
SCHEMBL28104718 0.88 PIP4K2A (0.46) PIP4K2ASCN10APRMT6ABL1CA12
SCHEMBL28840211 0.88 PIP4K2A (0.46) PIP4K2ASCN10APRMT6ABL1CA12
SCHEMBL29066294 0.84 CYP11B1 (0.50) PIP4K2ASCN10AABL1OPRM1KCNH2
SCHEMBL29597243 0.84 CYP11B1 (0.50) PIP4K2ASCN10AABL1OPRM1KCNH2
SCHEMBL505301 0.80 DRD1 (0.56) CA12CA9AURKATPX2SCN5A
SCHEMBL29066290 0.80 PIP4K2B (0.54) PIP4K2ACA12CA9KIF11CYP11B1
SCHEMBL18002361 0.80 AURKA (0.47) PIP4K2ACA12CA9AURKATPX2
SCHEMBL2318682 0.80 MAP4K4 (0.55) CYP11B1CYP11B2
SCHEMBL4035311 0.78 TRIM24 (0.51) PIP4K2AABL1CA12CA9AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104334529-B Compounds and compositions for inhibiting the activity of ABL1, ABL2, and BCR-ABL1 诺华股份有限公司 2017-03-15 CN disclosed
CN-104379574-B For suppressing the heterocyclic carbamate derivatives of the activity of ABL1, ABL2 and BCR ABL1 诺华股份有限公司 2017-03-01 CN disclosed
CN-104302634-B Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 诺华股份有限公司 2017-02-08 CN disclosed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed